In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe impact of wight-loss drugs to our business 'is negligible', says Medtronic CEOGeoff Martha, Medtronic CEO, joins 'Closing Bell Overtime' to talk quarterly results, the impact of weight-loss drugs, and more.
Persons:
Geoff Martha
Locations:
wight